Biomedical Engineering Reference
In-Depth Information
[24] Liu Z, Liu S, Wang f, Liu S, Chen X. Noninvasive imaging of tumor integrin expression
using (18)f-labeled RgD dimer peptide with peg (4) linkers. eur J Nucl med mol
Imaging 2009;
36
:1296-1307.
[25] bao A, goins b, Klipper R, Negrete g, mahindaratne m, phillips WT. A novel liposome
radiolabeling method using 99mTc-“SNS/S” complexes: in vitro and
in vivo
evaluation.
J pharm Sci 2003;
92
:1893-1904.
[26] boerman OC, Laverman p, Oyen WJg, Corstens fHm, Storm g. Radiolabeled liposomes
for scintigraphic imaging. prog Lipid Res 2000;
39
:461-475.
[27] phillips WT. Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev
1999;
37
:13-32.
[28] phillips WT, goins bA, bao A. Radioactive liposomes. Wiley Interdiscip Rev Nanomed
Nanobiotechnol 2009;
1
:69-83.
[29] Sofou S. Surface-active liposomes for targeted cancer therapy. Nanomedicine 2007;
2
:
711-724.
[30] gomes Cm, Abrunhosa AJ, Ramos p, pauwels eKJ. molecular imaging with SpeCT as
a tool for drug development. Adv Drug Deliv Rev 2011;
63
:547-554.
[31] Jarzyna pA, gianella A, Skajaa T, Knudsen g, Deddens LH, Cormode Dp, fayad ZA,
mulder WJm. multifunctional imaging nanoprobes. Wiley Interdiscip Rev Nanomed
Nanobiotechnol 2010;
2
:138-150.
[32] benezra m, penate-medina O, Zanzonico pb, Schaer D, Ow H, burns A, DeStanchina
e, Longo V, Herz e, Iyer S, Wolchok J, Larson Sm, Wiesner U, bradbury mS. multimodal
silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
J Clin Invest 2011;
121
:2768-2780.
[33] Welch mJ, Hawker CJ, Wooley KL. The advantages of nanoparticles for peT. J Nucl
med 2009;
50
:1743-1746.
[34] Schluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CHJ, Alabi CA, mack bC,
Davis me. pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from peT
imaging and tumor histological measurements. proc Natl Acad Sci U S A 2009;
106
:
11394-11399.
[35] Liu Y, Welch mJ. Nanoparticles labeled with positron emitting nuclides: advantages,
methods, and applications. bioconjug Chem 2012;
23
:671-682.
[36] Hong H, Zhang Y, Sun J, Cai W. molecular imaging and therapy of cancer with radiola-
beled nanoparticles. Nano Today 2009;
4
:399-413.
[37] minchin Rf, martin DJ. minireview: nanoparticles for molecular imaging—an overview.
endocrinology 2010;
151
:474-481.
[38] Kagadis gC, Loudos g, Katsanos K, Langer Sg, Nikiforidis gC.
In vivo
small animal
imaging: current status and future prospects. med phys 2010;
37
:6421-6442.
[39] Aweda TA, meares Cf. Combination of isothermal titration calorimetry and time-resolved
luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics.
methods 2012;
56
:145-153.
[40] Wadas TJ, Deng H, Sprague Je, Zheleznyak A, Weilbaecher KN, Anderson CJ. Targeting
the alphavbeta3 integrin for small-animal peT/CT of osteolytic bone metastases. J Nucl
med 2009;
50
:1873-1880.
[41] Rossin R. Radiolabeled nanoplatforms: imaging hot bullets hitting their target. In: Chen Z,
editor.
Nanoplatform-Based Molecular Imaging
. Hoboken, NJ: John Wiley & Sons, Inc;
2011. p 399-429.
Search WWH ::
Custom Search